ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

Tipping Resigned Forom ACS Following Volunteer Discontent

September 27, 1991

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes

April 7, 1978